Pharmaceutical Industry Information Portal

HomeNews

News

Eisai and BMS Enter Into Strategic Collaboration for MORAb-202 Antibody Drug Conjugate

Bristol Myers Squibb will pay $650 million U.S. dollars to Eisai including $200 million U.S. dollars as payment toward Eisai research and development expenses.

Latest patent reforms to further bolster innovative pharma research in China

According to GlobalData’s Pharma Intelligence Center Chinese patent authority is ranked on the top with 16,983 pharmaceutical grants issued so far in H1 2021.

Positive results were obtained for the drug Zanubrutinib in a comparative trial with Isrutinib

Brukinsa® (zanubrutinib) is under regulatory review for relapsed, refractory MCL in the Russian Federation with potential approval at the end of the 2021.

COVID-19 pathogenetic treatment is approved as an additional indication for olokizumab

Approval for a new indication will help healthcare professionals make streamlined decisions to administer preemptive anticytokine therapy.

Russia’s First Covid-19 Express Test Receives EU Certification

The company is planning deliveries to the EU in the near future, where the market in volume terms amounts to hundreds of millions of tests per month.

CureVac COVID-19 vaccine proved only 47% effective – CureVac shares fell by as much as 52%

CureVac shares fell by as much as 52% on Thursday after the German biotech’s COVID-19 vaccine proved only 47% effective in an initial trial,...
spot_img

Expert Articles

spot_img